Advisory Committee on the Medical Uses of Isotopes: Meeting Notice, 81579 [2024-23168]
Download as PDF
<![CDATA[
Federal Register / Vol. 89, No. 195 / Tuesday, October 8, 2024 / Notices
Electronic copies of this Federal
Register notice are available at https://
www.regulations.gov. This notice, as
well as news releases and other relevant
information, are also available on the
Advisory Board’s web page at https://
www.dol.gov/owcp/energy/regs/
compliance/AdvisoryBoard.htm.
For further information regarding this
meeting, you may contact Ryan Jansen,
Designated Federal Officer, at
jansen.ryan@dol.gov, or Carrie Rhoads,
Alternate Designated Federal Officer, at
rhoads.carrie@dol.gov, U.S. Department
of Labor, 200 Constitution Avenue NW,
Suite S–3524, Washington, DC 20210,
telephone (202) 343–5580.
This is not a toll-free number.
Signed at Washington, DC, this 3rd day of
October, 2024.
Christopher Godfrey,
Director, Office of Workers’ Compensation
Programs.
[FR Doc. 2024–23266 Filed 10–7–24; 8:45 am]
BILLING CODE 4510–CR–P
NUCLEAR REGULATORY
COMMISSION
Advisory Committee on the Medical
Uses of Isotopes: Meeting Notice
U.S. Nuclear Regulatory
Commission.
ACTION: Notice of meeting.
AGENCY:
The U.S. Nuclear Regulatory
Commission (NRC) will convene a
meeting of the Advisory Committee on
the Medical Uses of Isotopes (ACMUI)
on November 4–5, 2024. A sample of
agenda items to be discussed during the
public session includes: an overview of
the Advance Act; an update on the
Medical Radiation Safety Team’s
activities; ACMUI bylaws update; status
of patient release guidance revision;
NRC review of recent yttrium-90
microsphere medical events; and NRC
evaluation of current patient waste
regulations and guidance. The agenda is
subject to change. The current agenda
SUMMARY:
Date
Public Participation: Any member of
the public who wishes to participate in
the teleconference should contact Ms.
Armstead and Ms. Roszkowski using the
contact information below.
Contact Information: Ms. L.
Armstead, email: lxa5@nrc.gov and Ms.
T. Roszkowski, email: vnr@nrc.gov.
ddrumheller on DSK120RN23PROD with NOTICES1
Conduct of the Meeting
The ACMUI Chair, Dr. Hossein Jadvar,
will preside over the meeting. Dr. Jadvar
will conduct the meeting in a manner
that will facilitate the orderly conduct of
business. The following procedures
apply to public participation in the
meeting:
1. Persons who wish to provide a
written statement should submit an
electronic copy to Ms. L. Armstead and
Ms. T. Roszkowski using the contact
information listed above. All submittals
must be received by the close of
business on October 29, 2024, and must
only pertain to the topics on the agenda.
2. Questions and comments from
members of the public will be permitted
during the meeting, at the discretion of
the ACMUI Chair.
17:23 Oct 07, 2024
Jkt 265001
and any updates will be available on the
ACMUI’s Meetings and Related
Documents web page at https://
www.nrc.gov/reading-rm/doccollections/acmui/meetings/2024.html
or by emailing Ms. L. Armstead and T.
Roszkowski at the contact information
below.
Purpose: Discuss issues related to 10
CFR part 35 Medical Use of Byproduct
Material.
Date and Time for Open Sessions:
November 4, 2024, from 10:00 a.m. to
4:35 p.m. EST.
Date and Time for Closed Session:
November 5, 2024, from 9:30 a.m. to
11:30 a.m. EST. This session will be
closed to conduct the ACMUI’s required
annual training.
Address for Public Meeting: This is a
virtual meeting
Webinar information (Microsoft Teams)
November 4–5, 2024 ................................................................
VerDate Sep<11>2014
81579
Link: https://teams.microsoft.com/l/meetup-join/19%3ameeting_
M2Q3MzczZWUtNGUxZS00ZWNlL
ThmNmUtNjM4Y2ZhYTYxYTA0%40thread.v2/0?context=%7b%22Tid%22%3
a%22e8d01475-c3b5-436a-a065-5def4c64f52e%22%2c%22O
id%22%3a%22304f46bf-32c2-4e0f-912c-878db895e74a%22%7d.
Meeting ID: 294 578 901 723.
Passcode: UaHF5t.
Call in number (audio only): +1 301–576–2978, Silver Spring, MD.
Phone Conference ID: 277 173 020#.
3. The draft transcript and meeting
summary will be available on ACMUI’s
website https://www.nrc.gov/readingrm/doc-collections/acmui/meetings/
2024.html on or about December 17,
2024.
4. Persons who require special
services, such as those for the hearing
impaired, should notify Ms. L.
Armstead and Ms. T. Roszkowski of
their planned participation.
This meeting will be held in
accordance with the Atomic Energy Act
of 1954, as amended (primarily Section
161a); the Federal Advisory Committee
Act (5 U.S.C. App); and the
Commission’s regulations in title 10 of
the Code of Federal Regulations, part 7.
Dated at Rockville, Maryland this this 2nd
day of October, 2024.
For the U.S. Nuclear Regulatory
Commission.
Russell E. Chazell,
Federal Advisory Committee Management
Officer.
[FR Doc. 2024–23168 Filed 10–7–24; 8:45 am]
BILLING CODE 7590–01–P
PO 00000
Frm 00163
Fmt 4703
Sfmt 4703
NUCLEAR REGULATORY
COMMISSION
[Docket No. 70–3103; NRC–2024–0176]
Louisiana Energy Services, LLC, dba
Urenco USA; National Enrichment
Facility; License Amendment
Application
Nuclear Regulatory
Commission.
ACTION: Opportunity to request a hearing
and to petition for leave to intervene;
order imposing procedures.
AGENCY:
The U.S. Nuclear Regulatory
Commission (NRC) staff accepted and
docketed an application for the
amendment of Special Nuclear
Materials License No. SNM–2010,
submitted by Louisiana Energy Services,
LLC, dba Urenco USA dated November
30, 2023. The amended license would
authorize the applicant to modify the
National Enrichment Facility, located in
Eunice, New Mexico, to increase
enrichment from 5.5 weight percent
Uranium-235 (U–235) to less than 10
weight percent U–235. Because this
amendment request contains Sensitive
SUMMARY:
E:\FR\FM\08OCN1.SGM
08OCN1
]]>Agencies
[Federal Register Volume 89, Number 195 (Tuesday, October 8, 2024)]
[Notices]
[Page 81579]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-23168]
=======================================================================
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
Advisory Committee on the Medical Uses of Isotopes: Meeting
Notice
AGENCY: U.S. Nuclear Regulatory Commission.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) will convene a
meeting of the Advisory Committee on the Medical Uses of Isotopes
(ACMUI) on November 4-5, 2024. A sample of agenda items to be discussed
during the public session includes: an overview of the Advance Act; an
update on the Medical Radiation Safety Team's activities; ACMUI bylaws
update; status of patient release guidance revision; NRC review of
recent yttrium-90 microsphere medical events; and NRC evaluation of
current patient waste regulations and guidance. The agenda is subject
to change. The current agenda and any updates will be available on the
ACMUI's Meetings and Related Documents web page at https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2024.html or by emailing Ms.
L. Armstead and T. Roszkowski at the contact information below.
Purpose: Discuss issues related to 10 CFR part 35 Medical Use of
Byproduct Material.
Date and Time for Open Sessions: November 4, 2024, from 10:00 a.m.
to 4:35 p.m. EST.
Date and Time for Closed Session: November 5, 2024, from 9:30 a.m.
to 11:30 a.m. EST. This session will be closed to conduct the ACMUI's
required annual training.
Address for Public Meeting: This is a virtual meeting
------------------------------------------------------------------------
Webinar information (Microsoft
Date Teams)
------------------------------------------------------------------------
November 4-5, 2024..................... Link: https://teams.microsoft.com/l/meetup-join/19%3ameeting_M2Q3MzczZWUtNGUxZS00ZWNlLThmNmUtNjM4Y2ZhYTYxYTA0%40thread.v2/0?context=%7b%22Tid%22%3a%22e8d01475-c3b5-436a-a065-5def4c64f52e%22%2c%22Oid%22%3a%22304f46bf-32c2-4e0f-912c-878db895e74a%22%7d.
Meeting ID: 294 578 901 723.
Passcode: UaHF5t.
Call in number (audio only): +1
301-576-2978, Silver Spring,
MD.
Phone Conference ID: 277 173
020#.
------------------------------------------------------------------------
Public Participation: Any member of the public who wishes to
participate in the teleconference should contact Ms. Armstead and Ms.
Roszkowski using the contact information below.
Contact Information: Ms. L. Armstead, email: [email protected] and Ms.
T. Roszkowski, email: [email protected].
Conduct of the Meeting
The ACMUI Chair, Dr. Hossein Jadvar, will preside over the meeting.
Dr. Jadvar will conduct the meeting in a manner that will facilitate
the orderly conduct of business. The following procedures apply to
public participation in the meeting:
1. Persons who wish to provide a written statement should submit an
electronic copy to Ms. L. Armstead and Ms. T. Roszkowski using the
contact information listed above. All submittals must be received by
the close of business on October 29, 2024, and must only pertain to the
topics on the agenda.
2. Questions and comments from members of the public will be
permitted during the meeting, at the discretion of the ACMUI Chair.
3. The draft transcript and meeting summary will be available on
ACMUI's website https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2024.html on or about December 17, 2024.
4. Persons who require special services, such as those for the
hearing impaired, should notify Ms. L. Armstead and Ms. T. Roszkowski
of their planned participation.
This meeting will be held in accordance with the Atomic Energy Act
of 1954, as amended (primarily Section 161a); the Federal Advisory
Committee Act (5 U.S.C. App); and the Commission's regulations in title
10 of the Code of Federal Regulations, part 7.
Dated at Rockville, Maryland this this 2nd day of October, 2024.
For the U.S. Nuclear Regulatory Commission.
Russell E. Chazell,
Federal Advisory Committee Management Officer.
[FR Doc. 2024-23168 Filed 10-7-24; 8:45 am]
BILLING CODE 7590-01-P
